Skip to main content

CRISPR/Cas9-mediated generation of a Plac8 knockout mouse model

Abstract

Placenta specific 8 (PLAC8, also known as ONZIN) is a multi-functional protein that is highly expressed in the intestine, lung, spleen, and innate immune cells, and is involved in various diseases, including cancers, obesity, and innate immune deficiency. Here, we generated a Plac8 knockout mouse using the CRISPR/Cas9 system. The Cas9 mRNA and two single guide RNAs targeting a region near the translation start codon at Plac8 exon 2 were microinjected into mouse zygotes. This successfully eliminated the conventional translation start site, as confirmed by Sanger sequencing and PCR genotyping analysis. Unlike the previous Plac8 deficient models displaying increased adipose tissue and body weights, our male Plac8 knockout mice showed rather lower body weight than sex-matched littermate controls, though the only difference between these two mouse models is genetic context. Differently from the previously constructed embryonic stem cell-derived Plac8 knockout mouse that contains a neomycin resistance cassette, this knockout mouse model is free from a negative selection marker or other external insertions, which will be useful in future studies aimed at elucidating the multi-functional and physiological roles of PLAC8 in various diseases, without interference from exogenous foreign DNA.

References

  1. 1.

    Artelt P, Grannemann R, Stocking C, Friel J, Bartsch J, Hauser H. The prokaryotic neomycin-resistance-encoding gene acts as a transcriptional silencer in eukaryotic cells. Gene 1991; 99(2): 249–254.

    CAS  PubMed  Article  Google Scholar 

  2. 2.

    Biankin AV, Waddell N, Kassahn KS, Gingras MC, Muthuswamy LB, Johns AL, Miller DK, Wilson PJ, Patch AM, Wu J, Chang DK, Cowley MJ, Gardiner BB, Song S, Harliwong I, Idrisoglu S, Nourse C, Nourbakhsh E, Manning S, Wani S, Gongora M, Pajic M, Scarlett CJ, Gill AJ, Pinho AV, Rooman I, Anderson M, Holmes O, Leonard C, Taylor D, Wood S, Xu Q, Nones K, Fink JL, Christ A, Bruxner T, Cloonan N, Kolle G, Newell F, Pinese M, Mead RS, Humphris JL, Kaplan W, Jones MD, Colvin EK, Nagrial AM, Humphrey ES, Chou A, Chin VT, Chantrill LA, Mawson A, Samra JS, Kench JG, Lovell JA, Daly RJ, Merrett ND, Toon C, Epari K, Nguyen NQ, Barbour A, Zeps N; Australian Pancreatic Cancer Genome Initiative, Kakkar N, Zhao F, Wu YQ, Wang M, Muzny DM, Fisher WE, Brunicardi FC, Hodges SE, Reid JG, Drummond J, Chang K, Han Y, Lewis LR, Dinh H, Buhay CJ, Beck T, Timms L, Sam M, Begley K, Brown A, Pai D, Panchal A, Buchner N, De Borja R, Denroche RE, Yung CK, Serra S, Onetto N, Mukhopadhyay D, Tsao MS, Shaw PA, Petersen GM, Gallinger S, Hruban RH, Maitra A, Iacobuzio-Donahue CA, Schulick RD, Wolfgang CL, Morgan RA, Lawlor RT, Capelli P, Corbo V, Scardoni M, Tortora G, Tempero MA, Mann KM, Jenkins NA, Perez-Mancera PA, Adams DJ, Largaespada DA, Wessels LF, Rust AG, Stein LD, Tuveson DA, Copeland NG, Musgrove EA, Scarpa A, Eshleman JR, Hudson TJ, Sutherland RL, Wheeler DA, Pearson JV, McPherson JD, Gibbs RA, Grimmond SM. Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature 2012; 491(7424): 399–405.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  3. 3.

    Brabletz T, Hlubek F, Spaderna S, Schmalhofer O, Hiendlmeyer E, Jung A, Kirchner T. Invasion and metastasis in colorectal cancer: epithelial-mesenchymal transition, mesenchymal-epithelial transition, stem cells and beta-catenin. Cells Tissues Organs 2005; 179(1-2): 56–65.

    CAS  PubMed  Article  Google Scholar 

  4. 4.

    Brouns SJ, Jore MM, Lundgren M, Westra ER, Slijkhuis RJ, Snijders AP, Dickman MJ, Makarova KS, Koonin EV, van der Oost J. Small CRISPR RNAs guide antiviral defense in prokaryotes. Science 2008; 321(5891): 960–964.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  5. 5.

    Choi JY, Yun WB, Kim JE, Lee MR, Park JJ, Song BR, Kim HR, Park JW, Kang MJ, Kang BC, Lee HW, Hwang DY. Successful development of squamous cell carcinoma and hyperplasia in RGEN-mediated p27 KO mice after the treatment of DMBA and TPA. Lab Anim Res 2018; 34(3): 118–125.

    PubMed  PubMed Central  Article  Google Scholar 

  6. 6.

    Choy MC, Visvanathan K, De Cruz P. An Overview of the Innate and Adaptive Immune System in Inflammatory Bowel Disease. Inflamm Bowel Dis 2017; 23(1): 2–13.

    PubMed  Article  Google Scholar 

  7. 7.

    Couillard C, Mauriège P, Imbeault P, Prud’homme D, Nadeau A, Tremblay A, Bouchard C, Després JP. Hyperleptinemia is more closely associated with adipose cell hypertrophy than with adipose tissue hyperplasia. Int J Obes Relat Metab Disord 2000; 24(6): 782–788.

    CAS  PubMed  Article  Google Scholar 

  8. 8.

    Doench JG, Fusi N, Sullender M, Hegde M, Vaimberg EW, Donovan KF, Smith I, Tothova Z, Wilen C, Orchard R, Virgin HW, Listgarten J, Root DE. Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPRCas9. Nat Biotechnol 2016; 34(2): 184–191.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  9. 9.

    Galaviz-Hernandez C, Stagg C, de Ridder G, Tanaka TS, Ko MS, Schlessinger D, Nagaraja R. Plac8 and Plac9, novel placentalenriched genes identified through microarray analysis. Gene 2003; 309(2): 81–89.

    CAS  PubMed  Article  Google Scholar 

  10. 10.

    Gukovsky I, Li N, Todoric J, Gukovskaya A, Karin M. Inflammation, autophagy, and obesity: common features in the pathogenesis of pancreatitis and pancreatic cancer. Gastroenterology 2013; 144(6): 1199–1209.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  11. 11.

    Hickey MJ, Kubes P. Intravascular immunity: the host-pathogen encounter in blood vessels. Nat Rev Immunol 2009; 9(5): 364–375.

    CAS  PubMed  Article  Google Scholar 

  12. 12.

    Hsu PD, Scott DA, Weinstein JA, Ran FA, Konermann S, Agarwala V, Li Y, Fine EJ, Wu X, Shalem O, Cradick TJ, Marraffini LA, Bao G, Zhang F. DNA targeting specificity of RNA-guided Cas9 nucleases. Nat Biotechnol 2013; 31(9): 827–832.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  13. 13.

    Jimenez-Preitner M, Berney X, Thorens B. Plac8 is required for white adipocyte differentiation in vitro and cell number control in vivo. PLoS One 2012; 7(11): e48767.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  14. 14.

    Jimenez-Preitner M, Berney X, Uldry M, Vitali A, Cinti S, Ledford JG, Thorens B. Plac8 is an inducer of C/EBPβ required for brown fat differentiation, thermoregulation, and control of body weight. Cell Metab 2011; 14(5): 658–670.

    CAS  PubMed  Article  Google Scholar 

  15. 15.

    Jimenez-Preitner M, Berney X, Uldry M, Vitali A, Cinti S, Ledford JG, Thorens B. Plac8 is an inducer of C/EBPβ required for brown fat differentiation, thermoregulation, and control of body weight. Cell Metab 2011; 14(5): 658–670.

    CAS  PubMed  Article  Google Scholar 

  16. 16.

    Kaistha BP, Lorenz H, Schmidt H, Sipos B, Pawlak M, Gierke B, Kreider R, Lankat-Buttgereit B, Sauer M, Fiedler L, Krattenmacher A, Geisel B, Kraus JM, Frese KK, Kelkenberg S, Giese NA, Kestler HA, Gress TM, Buchholz M. PLAC8 Localizes to the Inner Plasma Membrane of Pancreatic Cancer Cells and Regulates Cell Growth and Disease Progression through Critical Cell-Cycle Regulatory Pathways. Cancer Res 2016; 76(1): 96–107.

    CAS  PubMed  Article  Google Scholar 

  17. 17.

    Kang Y, Massagué J. Epithelial-mesenchymal transitions: twist in development and metastasis. Cell 2004; 118(3): 277–279.

    CAS  PubMed  Article  Google Scholar 

  18. 18.

    Kim JH, Cho EY, Kwon E, Kim WH, Park JS, Lee YS, Yun JW, Kang BC. Gold thread implantation promotes hair growth in human and mice. Lab Anim Res 2017; 33(4): 291–297.

    PubMed  PubMed Central  Article  Google Scholar 

  19. 19.

    Kinsey C, Balakrishnan V, O’Dell MR, Huang JL, Newman L, Whitney-Miller CL, Hezel AF, Land H. Plac8 links oncogenic mutations to regulation of autophagy and is critical to pancreatic cancer progression. Cell Rep 2014; 7(4): 1143–1155.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  20. 20.

    Krzizek EC, Brix JM, Herz CT, Kopp HP, Schernthaner GH, Schernthaner G, Ludvik B. Prevalence of Micronutrient Deficiency in Patients with Morbid Obesity Before Bariatric Surgery. Obes Surg 2018; 28(3): 643–648.

    PubMed  Article  Google Scholar 

  21. 21.

    Lachmann PJ. Microbial subversion of the immune response. Proc Natl Acad Sci U S A 2002; 99(13): 8461–8462.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  22. 22.

    Ledford JG, Kovarova M, Koller BH. Impaired host defense in mice lacking ONZIN. J Immunol 2007; 178(8): 5132–5143.

    CAS  PubMed  Article  Google Scholar 

  23. 23.

    Lee JH, Rho JI, Devkota S, Sung YH, Lee HW. Developing genetically engineered mouse models using engineered nucleases: Current status, challenges, and the way forward. Drug Discov Today: Disease Models 2016; 20: 13–20.

    Article  Google Scholar 

  24. 24.

    Li C, Ma H, Wang Y, Cao Z, Graves-Deal R, Powell AE, Starchenko A, Ayers GD, Washington MK, Kamath V, Desai K, Gerdes MJ, Solnica-Krezel L, Coffey RJ. Excess PLAC8 promotes an unconventional ERK2-dependent EMT in colon cancer. J Clin Invest 2014; 124(5): 2172–2187.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  25. 25.

    McMurray HR, Sampson ER, Compitello G, Kinsey C, Newman L, Smith B, Chen SR, Klebanov L, Salzman P, Yakovlev A, Land H. Synergistic response to oncogenic mutations defines gene class critical to cancer phenotype. Nature 2008; 453(7198): 1112–1116.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  26. 26.

    Michl P, Gress TM. Current concepts and novel targets in advanced pancreatic cancer. Gut 2013; 62(2): 317–326.

    CAS  PubMed  Article  Google Scholar 

  27. 27.

    Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, Stein KD, Alteri R, Jemal A. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin 2016; 66(4): 271–289.

    PubMed  PubMed Central  Article  Google Scholar 

  28. 28.

    Müller U. Ten years of gene targeting: targeted mouse mutants, from vector design to phenotype analysis. Mech Dev 1999; 82(1-2): 3–21.

    PubMed  Article  Google Scholar 

  29. 29.

    Paquet D, Kwart D, Chen A, Sproul A, Jacob S, Teo S, Olsen KM, Gregg A, Noggle S, Tessier-Lavigne M. Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9. Nature 2016; 533(7601): 125–129.

    CAS  PubMed  Article  Google Scholar 

  30. 30.

    Roh JI, Cheong C, Sung YH, Lee J, Oh J, Lee BS, Lee JE, Gho YS, Kim DK, Park CB, Lee JH, Lee JW, Kang SM, Lee HW. Perturbation of NCOA6 leads to dilated cardiomyopathy. Cell Rep 2014; 8(4): 991–998.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  31. 31.

    Roh JI, Kim Y, Oh J, Kim Y, Lee J, Lee J, Chun KH, Lee HW. Hexokinase 2 is a molecular bridge linking telomerase and autophagy. PLoS One 2018; 13(2): e0193182.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  32. 32.

    Roh JI, Lee J, Park SU, Kang YS, Lee J, Oh AR, Choi DJ, Cha JY, Lee HW. CRISPR-Cas9-mediated generation of obese and diabetic mouse models. Exp Anim 2018; 67(2): 229–237.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  33. 33.

    Segal AW. How neutrophils kill microbes. Annu Rev Immunol 2005; 23: 197–223.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  34. 34.

    Sung YH, Kim JM, Kim HT, Lee J, Jeon J, Jin Y, Choi JH, Ban YH, Ha SJ, Kim CH, Lee HW, Kim JS. Highly efficient gene knockout in mice and zebrafish with RNA-guided endonucleases. Genome Res 2014; 24(1): 125–131.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  35. 35.

    Valera A, Perales JC, Hatzoglou M, Bosch F. Expression of the neomycin-resistance (neo) gene induces alterations in gene expression and metabolism. Hum Gene Ther 1994; 5(4): 449–456.

    CAS  PubMed  Article  Google Scholar 

  36. 36.

    Witko-Sarsat V, Rieu P, Descamps-Latscha B, Lesavre P, Halbwachs-Mecarelli L. Neutrophils: molecules, functions and pathophysiological aspects. Lab Invest 2000; 80(5): 617–653.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  37. 37.

    Wright C, Simone NL. Obesity and tumor growth: inflammation, immunity, and the role of a ketogenic diet. Curr Opin Clin Nutr Metab Care 2016; 19(4): 294–299.

    CAS  PubMed  Article  Google Scholar 

  38. 38.

    Wu X, Kriz AJ, Sharp PA. Target specificity of the CRISPR-Cas9 system. Quant Biol 2014; 2(2): 59–70.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  39. 39.

    Yoshiki A, Moriwaki K. Mouse phenome research: implications of genetic background. ILAR J 2006; 47(2): 94–102.

    CAS  PubMed  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding authors

Correspondence to Jae-il Roh or Jaehoon Lee or Byeong-Cheol Kang or Han-Woong Lee.

Rights and permissions

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://doi.org/creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Lee, H., Kim, J., Park, J. et al. CRISPR/Cas9-mediated generation of a Plac8 knockout mouse model. Lab Anim Res 34, 279–287 (2018). https://doi.org/10.5625/lar.2018.34.4.279

Download citation

Keywords

  • PLAC8
  • CRISPR/Cas9
  • mouse model